Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [111In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancer.
Saved in:
| Title: | Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [111In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancer. |
|---|---|
| Authors: | Chan, Conrad1 (AUTHOR), Prozzo, Vanessa1 (AUTHOR), Aghevlian, Sadaf1 (AUTHOR), Reilly, Raymond M.1,2,3,4 (AUTHOR) raymond.reilly@utoronto.ca |
| Source: | EJNMMI Radiopharmacy & Chemistry. 12/21/2022, Vol. 7 Issue 1, p1-21. 21p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 160907790 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [<superscript>111</superscript>In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Chan%2C+Conrad%22">Chan, Conrad</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Prozzo%2C+Vanessa%22">Prozzo, Vanessa</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aghevlian%2C+Sadaf%22">Aghevlian, Sadaf</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Reilly%2C+Raymond+M%2E%22">Reilly, Raymond M.</searchLink><relatesTo>1,2,3,4</relatesTo> (AUTHOR)<i> raymond.reilly@utoronto.ca</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22EJNMMI+Radiopharmacy+%26+Chemistry%22">EJNMMI Radiopharmacy & Chemistry</searchLink>. 12/21/2022, Vol. 7 Issue 1, p1-21. 21p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=160907790 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s41181-022-00186-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 21 StartPage: 1 Titles: – TitleFull: Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [111In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chan, Conrad – PersonEntity: Name: NameFull: Prozzo, Vanessa – PersonEntity: Name: NameFull: Aghevlian, Sadaf – PersonEntity: Name: NameFull: Reilly, Raymond M. IsPartOfRelationships: – BibEntity: Dates: – D: 21 M: 12 Text: 12/21/2022 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 2365421X Numbering: – Type: volume Value: 7 – Type: issue Value: 1 Titles: – TitleFull: EJNMMI Radiopharmacy & Chemistry Type: main |
| ResultId | 1 |